217 related articles for article (PubMed ID: 34544343)
1. Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
Liu H; Yu R; Gao Y; Li X; Guan X; Thomas K; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1774-1782. PubMed ID: 34544343
[TBL] [Abstract][Full Text] [Related]
2. Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.
Li XR; Xiu MH; Guan XN; Wang YC; Wang J; Leung E; Zhang XY
Neurotherapeutics; 2021 Apr; 18(2):1316-1324. PubMed ID: 33791970
[TBL] [Abstract][Full Text] [Related]
3. Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study.
Liu H; Liu H; Jiang S; Su L; Lu Y; Chen Z; Li X; Li X; Wang X; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1793-1803. PubMed ID: 34766896
[TBL] [Abstract][Full Text] [Related]
4. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
5. Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study.
Xiu M; Song X; Yang H; Huang X; Wu F; Zhang X
Curr Neuropharmacol; 2023; 21(10):2151-2158. PubMed ID: 37132112
[TBL] [Abstract][Full Text] [Related]
6. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
8. Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy.
Wang K; Xiu M; Su X; Wu F; Zhang X
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453331
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis.
Yang M; Wang C; Zhao G; Kong D; Liu L; Yuan S; Chen W; Feng C; Li Z
Curr Neuropharmacol; 2023; 21(2):340-352. PubMed ID: 35794775
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Padurariu M; Ciobica A; Dobrin I; Stefanescu C
Neurosci Lett; 2010 Aug; 479(3):317-20. PubMed ID: 20561936
[TBL] [Abstract][Full Text] [Related]
11. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
12. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia.
Djordjević VV; Kostić J; Krivokapić Ž; Krtinić D; Ranković M; Petković M; Ćosić V
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295651
[TBL] [Abstract][Full Text] [Related]
13. Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study.
Gao Z; Xiu M; Liu J; Wu F; Zhang X
Curr Neuropharmacol; 2024; 22(10):1733-1741. PubMed ID: 37859307
[TBL] [Abstract][Full Text] [Related]
14. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia.
Yuan X; Zhang P; Wang Y; Liu Y; Li X; Kumar BU; Hei G; Lv L; Huang XF; Fan X; Song X
Schizophr Res; 2018 Nov; 201():299-306. PubMed ID: 29859859
[TBL] [Abstract][Full Text] [Related]
15. Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.
Raffa M; Atig F; Mhalla A; Kerkeni A; Mechri A
BMC Psychiatry; 2011 Aug; 11():124. PubMed ID: 21810251
[TBL] [Abstract][Full Text] [Related]
16. Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia.
Li Z; Hu M; Zong X; He Y; Wang D; Dai L; Dong M; Zhou J; Cao H; Lv L; Chen X; Tang J
Sci Rep; 2015 Dec; 5():18553. PubMed ID: 26680692
[TBL] [Abstract][Full Text] [Related]
17. The effect of risperidone treatment on superoxide dismutase in schizophrenia.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
J Clin Psychopharmacol; 2003 Apr; 23(2):128-31. PubMed ID: 12640213
[TBL] [Abstract][Full Text] [Related]
18. Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain.
Stojković T; Radonjić NV; Velimirović M; Jevtić G; Popović V; Doknić M; Petronijević ND
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):192-9. PubMed ID: 22735395
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
Chen YQ; Li XR; Zhang L; Zhu WB; Wu YQ; Guan XN; Xiu MH; Zhang XY
J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
